Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. - Wikidata - wikimedia - TriplyDB

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

http://www.wikidata.org/entity/Q48235146

about

Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis Examining the association between salivary cortisol levels and subclinical measures of atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study Pharmacological Treatment of Heart Failure with Preserved Ejection Fraction Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".Cortisol responses to mental stress and the progression of coronary artery calcification in healthy men and women.Urinary cortisol and six-year risk of all-cause and cardiovascular mortality.Glucocorticoids Induce Cardiac Fibrosis via Mineralocorticoid Receptor in Oxidative Stress: Contribution of Elongation Factor Eleven-Nineteen Lysine-Rich Leukemia (ELL).Aldosterone and mortality in hemodialysis patients: role of volume overload.Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression.Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Regulation of circulating progenitor cells in left ventricular dysfunction.Psychobiology of depression/distress in congestive heart failure Examination of the potential association of stress with morbidity and mortality outcomes in patient with heart failure.Corticosteroids Mediate Heart Failure-Induced Depression through Reduced σ1-Receptor Expression.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Does depression impact cognitive impairment in patients with heart failure?Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.Sleep Disruption is Associated with Increased Ventricular Ectopy and Cardiac Arrest in Hospitalized Adults.Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction.Long term outcome of Aldosteronism after target treatments.Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.New and emerging biomarkers of heart failure.Understanding how we age: insights into inflammaging Hypoglycaemia increases aldosterone in a dose-dependent fashion.Targeting the aldosterone pathway in cardiovascular disease.Mineralocorticoid receptor antagonists for heart failure.Prevention of heart failure in the elderly: when, where and how to begin?Aldosterone in heart disease.Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.Cardiac myocyte-fibroblast interactions and the coronary vasculature.Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.How are depression and type D personality associated with outcomes in chronic heart failure patients?

P2860

Q24311808-66FB47C4-FF0A-4C90-8AF1-4BBBCDF85733 Q24648449-0020A9AF-1A64-45E8-9604-097E28BA5CAC Q28580617-5988A921-3555-4E81-B448-86B75BB0750F Q33607862-E0C62D7D-4951-4A0F-8E09-4258D872DCB4 Q33856656-DB69075E-3126-4443-9FF2-2332FC8BA59B Q33871492-D1604338-253B-4DB8-85A8-A2CDBCF1E7A5 Q33885952-DDC1425E-A14D-4F87-A443-6A1462C87527 Q34014004-99979295-C105-4B38-8CA9-FB7A47F4E19B Q34121798-0473A601-7B84-4593-A51A-AAD2F523E947 Q34157296-B0E7AF5A-3EEC-4591-B121-BB55E4D65459 Q34262406-83A4C096-4ED1-4ADD-8554-3A7FBA1C3059 Q34403980-381F177D-A6F9-4645-BA7F-2D5E22727084 Q34612156-06FA533A-B005-4D60-8F7E-350F5023FC58 Q34726918-DC7BB140-E492-40C4-BB7C-8E90ECD220C9 Q34784461-B269124E-EC53-4DFE-9932-0BFBFA80ADB2 Q34981416-F3AA9DB7-A024-4ED5-964C-FD893193BE8C Q34989233-85908F6C-25CA-4F57-A9F4-5D0C226FAC48 Q35293910-B5E4EE33-D17A-416D-B2DE-9B5482195B39 Q35911866-DEEA83FD-510A-4107-8462-E8ECC3E44227 Q36163630-BF74CFA6-57DA-4622-8728-91FFA7575044 Q36167458-F74A88B5-9E74-43D3-81C8-87BEC866CA5A Q36167914-BAA65757-34AB-4386-9667-F37BE951670D Q36626365-44434E08-C2A2-4E65-954A-CF2B491EA9B2 Q36686531-07AA33ED-F46D-43FA-B478-185C51B74D12 Q36800757-5354C93C-CE30-43AE-8A88-307BF925FD66 Q36866650-F7E0DFD6-B976-4F86-98D7-588E4A6F10D0 Q37227936-6FF0E314-B4E4-4BAF-87EB-5CD912EBA8D6 Q37407146-7AB2C831-424B-4A1F-8394-B7E21304FC85 Q37419451-D007AF71-3AE9-4B07-8BF0-607317940F9A Q37514230-F06A932C-1BA7-4450-9DAB-230712BD5702 Q37581232-AF6B294F-E540-469C-840D-2B1F4C6600A9 Q37643031-5A6EAEE4-ED46-49AF-8EE3-0A6DACFBC661 Q37951665-070F67B5-BFF0-45B2-BE71-48828EA938D8 Q37955919-A760C0D6-4C4E-471B-BA6E-24ADC94C02E0 Q37978190-E687E72B-7CD5-4453-AEDC-F7152FB8CD9E Q37981980-3A9ECE67-CC91-454C-80C6-C517C5C618DD Q38005732-87493ED3-FDAA-4ADE-A839-054C09290BBD Q38044304-417F71AC-470A-4143-9BF5-2C20542EEA17 Q38072297-991F3E90-8214-4106-896F-60387C4B8BF3 Q38105488-2BDE9698-7501-4D5F-AE80-3873C7B9912A

P2860

Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.

http://www.wikidata.org/entity/Q48235146

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Complementary and incremental ...... rone in chronic heart failure.

@en

Complementary and incremental ...... rone in chronic heart failure.

@nl

type

label

Complementary and incremental ...... rone in chronic heart failure.

@en

Complementary and incremental ...... rone in chronic heart failure.

@nl

prefLabel

Complementary and incremental ...... rone in chronic heart failure.

@en

Complementary and incremental ...... rone in chronic heart failure.

@nl

P1433

Q48235146-0998A29F-B352-41B4-BEBE-BB4512375845

P1476

Q48235146-3195ADC0-347E-4B90-88D2-977976DEBFC5

P2093

Q48235146-0EE3486F-95D6-459D-84D4-046D76D51276

Q48235146-1A3F11B6-2D79-4E02-856F-AA578DAED6CD

Q48235146-20C9F107-48A8-458E-82D8-F75C0A60AE63

Q48235146-4DE1BC6E-B8CD-4E1B-8AC3-D3A9D14D1653

Q48235146-7C31E370-A7F2-4738-B7C4-579499E7DCF7

Q48235146-AE0D0AA0-0F2B-4554-BF58-539C72161FA3

Q48235146-AFD9A9DA-8184-43AF-AED5-DF0EA80A2056

Q48235146-E58C2256-9B08-4293-AD7E-61C304FFD5E7

P304

Q48235146-BA87BBE7-1FD6-4488-A7E4-61B162B8A976

P31

Q48235146-C55A5A02-EC05-4DBB-83FD-391CD4984A3E

P356

Q48235146-B4E982EB-6136-4800-87F6-F3D1304F6181

P407

Q48235146-4F8417CF-D3AD-4281-B5AA-3A849ACF03C5

P433

Q48235146-4F78C530-1761-47FC-89FD-CC8E334566A1

P478

Q48235146-474568AD-36C4-48FB-9AAB-FD76CCF4319A

P577

Q48235146-0AE02A86-A7BB-4999-AA0C-4B9FCE99DDD6

P5875

Q48235146-4499EF59-0ED5-4962-9132-EBBA10DDBCCD

P698

Q48235146-79002FE9-8A53-4A47-8591-B7B710CAD4CD

P921

Q48235146-16D0B367-4B81-4D82-B228-9D177BEA0DB7

Q48235146-6382a6d4-7f65-47ab-93e1-7d240a14fa0a

P356

CIRCULATIONAHA.106.653964

P1433

P1476

Complementary and incremental ...... rone in chronic heart failure.

@en

P2093

Bruno Allolio

http://www.w3.org/2001/XMLSchema#string

Christiane E Angermann

http://www.w3.org/2001/XMLSchema#string

Dirk Weismann

http://www.w3.org/2001/XMLSchema#string

Georg Ertl

http://www.w3.org/2001/XMLSchema#string

Gülmisal Güder

http://www.w3.org/2001/XMLSchema#string

Johann Bauersachs

http://www.w3.org/2001/XMLSchema#string

Stefan Frantz

http://www.w3.org/2001/XMLSchema#string

Stefan Störk

http://www.w3.org/2001/XMLSchema#string

P304

1754-1761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.106.653964

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6435555

http://www.w3.org/2001/XMLSchema#string

P698

17372171

http://www.w3.org/2001/XMLSchema#string

P921